Enovis Financial Ratios
ENOV / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score -0.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-79.5%
Profit Margin
-52.7%
Net Income / Revenue
Asset Turnover
0.59
Revenue / Total Assets
Equity Multiplier
2.57
Total Assets / Equity
Composite: -79.5% (reported: -79.5%)
Profitability
Liquidity
Current Ratio
2.02
Quick Ratio
1.04
Solvency
Interest Coverage
6.24
Efficiency
Asset Turnover
0.59
Inventory Turnover
1.54
Days Sales Outstanding
72 days
As of FY2025 · SEC 10-K · Updated Jul 2, 2026
Earnings Quality
Accrual Ratio
-32.8%
-12.9pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.